STAAR Surgical (STAA) Tops Q2 EPS by 2c, Beats on Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. AMZN
2. INTC
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to STAAR Surgical (STAA) Tops Q2 EPS by 2c, Beats on Revenue

STAAR Surgical Reports Second Quarter 2026 Results

August 12, 2026 4:01 PM EDT

Net Sales of $93.5 million, up 111% Y/Y

Net Income of $8.1 million, with GAAP EPS of $0.16

Adjusted EBITDA1 of $20.0 million, or $0.39 per diluted share

Earnings Call and Webcast Today at 5:30 PM Eastern

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today reported results for the second quarter ended July 3, 2026.

Second Quarter 2026... More